|
|
|
| Wu Yu’s experience in treating liver cancer with Pinelliae Rhizoma Pra-eparatum Cum Alumine, Arisaematis Rhizoma Preparatum, and Fritillariae Thunbergii Bulbus as main prescriptions |
| LIANG Biyan1 DONG Xiaojia2 WANG Lianmei3 HAO Tengteng4 WU Jiao4 ZHOU Rui4 ZHAO Hanqing5 WU Yu4 |
1.Traditional Chinese Medicine Center for Acquired Immunodeficiency Syndrome Prevention and Treatment, China Academy of Chinese Medical Sciences, Beijing 100700, China;
2.Department of Retired Cadres, China Academy of Chinese Medical Sciences, Beijing 100700, China;
3.Department of Medical, Fangshan Hospital Beijing University of Chinese Medicine, Beijing 102499, China;
4.Department of Oncology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China; 5.College of Traditional Chinese Medicine, Hebei University, Hebei Province, Baoding 071000, China
|
|
|
|
Abstract The occurrence of “phlegm” is related to congenital endowments and acquired multiple factors, as well as the resulting substances such as essence, blood, and body fluid, and the retained fluid caused by accumulation of body fluid. The process of phlegm formation affects the movement and excretion of body fluid due to the obstruction of the qi transformation function of the zang-fu viscera. Liver cancer is closely related to phlegm production. Professor Wu Yu believes that “phlegm” is an important pathogenic factor of liver cancer in Chinese medicine. “phlegm” is a necessary factor in the deve- lopment and metastasis of liver cancer and a participant from beginning to end. Eliminating phlegm method is a consistent principle in the treatment of liver cancer in traditional Chinese medicine. Liver cancer occurs with phlegm turbidities as evil, there is a strong lump in body, body fluid retention can form phlegm turbidities, phlegm turbidities stagnation, qi and blood operation is not smooth, a long time into the formation of cancer lumps, the treatment should dissipate phlegm and resolve masses and eliminate cancer lumps. Combining with the clinical treatment experience, the main prescription for the treatment of liver cancer is put forward, which includes Pinelliae Rhizoma Praeparatum Cum Alumine, Arisaematis Rhizoma Preparatum, and Fritillariae Thunbergii Bulbus. Among them, Pinelliae Rhizoma Praeparatum Cum Alumine, Arisaematis Rhizoma Preparatum eliminate dampness and phlegm, eliminate the visible cancer lumps, Fritillariae Thunbergii Bulbus dissipates phlegm and resolves masses, attack the visible cancer lumps.
|
|
|
|
|
|
[1] Huang DQ，Singal AG，Kono Y，et al. Changing global epi- demiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer [J]. Cell Metab，2022，34（7）：969-977.
[2] Xia C，Dong X，Li H，et al. Cancer statistics in China and United States，2022：profiles，trends，and determinants [J]. Chin Med J（Engl），2022，135（5）：584-590.
[3] Zheng RS，Zhang SW，Zeng HM，et al. Cancer incidence and mortality in China，2016 [J]. J Natl Cancer Cent，2022，2（1）：1-9.
[4] 国家卫生健康委办公厅.原发性肝癌诊疗指南（2022年版）[J].临床肝胆病杂志，2022，38（2）：288-303.
[5] 朱耀东，刘磊，巴赫，等.中医药参与中晚期原发性肝癌患者综合治疗的临床疗效和安全性分析[J].中西医结合肝病杂志，2023，33（1）：26-28.
[6] 王强，邓厚波，翟双庆，等.东北部地区名老中医刘铁军教授治疗肝癌学术思想及用药规律的研究[J].时珍国医国药，2020，31（12）：3014-3016.
[7] 安佰平.化痰解毒散结法治疗原发性肝癌疗效优势与特色研究[D].北京：北京中医药大学，2014.
[8] 陈顺泰.桔梗皂苷D基于JNK/PUMA通路诱导非小细胞肺癌凋亡的机制研究[D].北京：北京中医药大学，2021.
[9] 王恒，于淼，李伟楠，等.半夏化学成分及抗肿瘤作用机制研究进展[J].中医药导报，2021，27（8）：49-52.
[10] 崔迎霞.孙宏新主任医师应用半夏治疗恶性肿瘤经验[D].郑州：河南中医药大学，2018.
[11] 汪荣斌，王存琴，刘晓龙.天南星（虎掌南星）的化学成分和药理作用研究[J].长春中医药大学学报，2010，26（4）：590-592.
[12] 张艳，王成岗，刘西建.有毒中药治疗消化系统肿瘤的辨病用药研究[J].山东中医杂志，2014，33（9）：737-739.
[13] 施俊，叶敏，陆烨，等.魏品康从痰论治胃癌用药规律研究[J].中国中医药信息杂志，2017，24（10）：85-89.
[14] 孙禹，梁伟.浙贝母的化学成分、药理作用及临床应用研究进展[J].特产研究，2022，44（1）：87-92.
[15] 王新龙.基于数据挖掘技术总结王晞星教授对胆系恶性肿瘤的治疗经验[D].太原：山西省中医药研究院，2019.
[16] 刘雪娇，张雪云，张勇.基于miR-320/E2F转录因子1轴探讨天南星提取物对肺癌细胞顺铂耐药的影响及相关机制[J].实用心脑肺血管病杂志，2022，30（8）：19-23.
[17] 杨宗辉.天南星有效部位抗肝癌作用及其机制的研究[D].长春：吉林大学，2007.
[18] 吴红艳.杜仲叶多酚类物质提取工艺及抗氧化抗肿瘤研究[D].长沙：湖南农业大学，2020.
[19] 陈雷，彭骁，胡兵.半枝莲抗肿瘤作用及临床应用研究进展[J].新中医，2020，52（10）：14-18..
[20] 王雪梅，吴凡伟，李彦荣.基于王三虎“燥湿相混致癌说”探究半边莲治疗癌症的作用及物质基础[J].广州中医药大学学报，2022，39（1）：171-176.
[21] 李增，张瑞，张晓坚，等.石见穿多糖通过Wnt/β-catenin信号通路调控骨肉瘤细胞的迁移和侵袭[J].中成药，2020，42（9）：2324-2328.
[22] 王奇，姜建伟，章红燕.蛇六谷抗肿瘤作用及临床应用研究进展[J].山东中医药大学学报，2016，40（3）：291-293.
[23] 刘思佳，姚杰，宋雪，等.苍术属药用植物的化学成分、药理作用、临床应用概况[J].中华中医药学刊，2023，41（1）：151-154.
[24] 赵小强，赵静，张浩波，等.黄芪甲苷的提取、分离、纯化及其药理作用的研究进展[J].华西药学杂志，2022，37（6）：711-716.
[25] 戴慧，覃欣怡，端木彦涛，等.茯神的化学成分、药理作用及质量控制研究进展[J].江西中医药，2022，53（10）：68-72.
[26] 姚辛敏，周晓洁，周妍妍，等.远志化学成分及药理作用研究进展[J].中医药学报，2022，50（2）：103-107.
[27] 林贞妍，耿乐，刘璇，等.猪苓多糖的药理作用及机制研究进展[J/OL].中药药理与临床：1-15[2023-03-02].https：//doi.org/10.13412/j.cnki.zyyl.20220323.004. |
|
|
|
